Quantcast
Last updated on April 17, 2014 at 8:45 EDT

Latest thyroid cancer Stories

2013-11-13 08:29:25

SOUTH SAN FRANCISCO, Calif., Nov. 13, 2013 /PRNewswire/ -- Veracyte, Inc. (Nasdaq: VCYT) today announced that it presented new data suggesting the ability of its Afirma Gene Expression Classifier (GEC) to accurately identify medullary thyroid cancer (MTC) among thyroid nodule fine needle aspiration (FNA) samples that are indeterminate and sub-classified as Hurthle cell neoplasms by cytopathology. The findings were presented in a poster session at the American Society of...

2013-11-09 23:01:50

The Firm is actively investigating potential Januvia lawsuit claims on behalf of individuals who allegedly developed pancreatitis, pancreatic cancer or thyroid cancer due to their use of the Type 2 diabetes medication. New York, New York (PRWEB) November 09, 2013 The federal multidistrict litigation established for Januvia lawsuits (http://www.januvialawsuithelp.com) will hold its next Status Conference on November 21, 2013, Bernstein Liebhard LLP reports. According to court filings, at...

2013-10-30 23:23:12

The Firm is actively investigating potential Januvia lawsuit claims on behalf of individuals who allegedly developed pancreatitis, pancreatic cancer or thyroid cancer as a result of taking the Type 2 diabetes medication. New York, NY (PRWEB) October 30, 2013 A federal Januvia lawsuit litigation (http://www.januvialawsuithelp.com/) continued to progress in October with an initial status conference to discuss matters related to claims over the Type 2 diabetes drug, as well as other...

2013-10-23 16:29:37

SOUTH SAN FRANCISCO, Calif., Oct. 23, 2013 /PRNewswire/ -- Data from a new long-term, multicenter study confirm the accuracy of the Afirma Gene Expression Classifier (GEC) in identifying benign thyroid nodule fine needle aspiration (FNA) biopsies among those initially deemed indeterminate, or inconclusive, by cytopathology, Veracyte, Inc. announced today. The findings further support physicians' decision to avoid diagnostic surgery on such patients and monitor them instead - and...

Link Suggested Between Nervous System And Cancer
2013-10-15 12:24:53

UT Southwestern Medical Center A specific protein once thought to exist only in the brain may play a crucial role in a deadly form of thyroid cancer, as well as other cancers, and provide a fresh target for researchers seeking ways to stop its progression, UT Southwestern Medical Center researchers report today in Cancer Cell. The scientists found that over-activation of a certain protein in hormone-secreting cells helps fuel medullary thyroid cancer cells in mice as well as in human...

2013-10-14 23:01:48

The Firm is investigating Januvia lawsuits on behalf of individuals who developed pancreatic cancer, pancreatitis or thyroid cancer, allegedly due to their use of Januvia. New York, New York (PRWEB) October 14, 2013 Januvia lawsuits ( http://www.januvialawsuithelp.com/), as well as product liability claims involving other incretin mimetic drugs, are preparing to move forward in a multidistrict litigation established in U.S. District Court, Southern District of California, Bernstein...

2013-10-14 23:01:16

The Firm’s Byetta lawyers are investigating legal claims on behalf of individuals treated with the Type 2 diabetes drug who went on to develop pancreatic cancer, pancreatitis and thyroid cancer, allegedly due to Byetta. New York, NY (PRWEB) October 14, 2013 Byetta lawsuits (http://www.byettalawsuit2013.com/) alleging that use of the Type 2 diabetes drug caused patients to develop pancreatic cancer are moving forward in a multidistrict litigation now underway in U.S. District Court,...

2013-10-09 11:47:30

Findings from the first study to show a specific function of the immune system in the proliferation of thyroid cancer may ultimately change the course of treatment Researchers at the National Institutes of Health (NIH), Bethesda, MD, have taken the first steps to determine if a protein, called Programmed Death Ligand 1 (PD-L1), can help to predict which thyroid cancer patients will most likely have a recurrence of the disease. Study findings were presented today at the 2013 Clinical...

2013-09-30 10:15:46

Tumor genetics, cancer cell signaling discoveries pave way for use of new therapies For many years, patients with advanced thyroid cancer faced bleak prospects and no viable treatment options. But now, building on recent discoveries about the genetics and cell signaling pathways of thyroid tumors, researchers are developing exciting new weapons against the disease, using kinase inhibitors that target tumor cell division and blood vessels. Two recent clinical trials led by a researcher from...

2013-09-17 08:32:55

Singer Tony Harnell Joins Forces with American College of Endocrinology (ACE) to Advocate for Awareness During Thyroid Cancer Awareness Month JACKSONVILLE, Fla., Sept. 17, 2013 /PRNewswire/ -- "You have cancer." Those three words are among the most dreaded and powerful a person can hear. In the case of Tony Harnell, the diagnosis of thyroid cancer was doubly frightening. To view the multimedia assets associated with this release, please click:...